Lataa...
Emerging Immunotherapies for Parkinson Disease
Symptomatic treatment options for Parkinson disease have steadily improved, and individualized therapeutic approaches are becoming established for every stage of the disease. However, disease-modifying therapy with a causal approach is still unavailable. The central causative role of alpha-synuclein...
Tallennettuna:
| Julkaisussa: | Neurol Ther |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Healthcare
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534677/ https://ncbi.nlm.nih.gov/pubmed/30539376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-018-0122-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|